Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
Alfredomaria Lurati,1 Antonella Laria,1 Daniela Mazzocchi,1 Katia Angela Re,1 Maria Grazia Marrazza,1 Paola Maria Faggioli,2 Antonino Mazzone2 1Rheumatology Unit, Fornaroli Hospital Magenta Italy, Milan, Italy; 2Internal Medicine Unit, Legnano Hospital, Milan, ItalyCorrespondence: Alfredomaria Lurat...
Enregistré dans:
Auteurs principaux: | Lurati A, Laria A, Mazzocchi D, Re KA, Marrazza MG, Faggioli PM, Mazzone A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/25b05d17f5b84971bc43f6a35f853242 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
par: Findeisen KE, et autres
Publié: (2021) -
Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
par: Mysler E, et autres
Publié: (2021) -
The onset of rheumatoid arthritis following trauma
par: Brawer AE, et autres
Publié: (2016) -
Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
par: Almalag H, et autres
Publié: (2020) -
Management of rheumatoid arthritis during pregnancy: challenges and solutions
par: Krause ML, et autres
Publié: (2016)